| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | 0.0098 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.0062 | 1 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |